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1. Introduction
   There are many similarities anatomical, physiological, 
pharmacological and pathological between the nephron 
and the stria vascularis of the cochlea and hearing loss 
has been reported in patients with renal failure. The 
gross anatomy of the kidney and cochlea differs greatly, 
although there are many similarities at the ultra structural 
level. Both of them contain epithelial structures in close 
contact with their vascular supply. Basement membrane 
is found closely opposed to capillary endothelium in both 
Bawmans capsule and proximal renal tubule of the kidney 
and also around the capillaries of the stria vascularis.
   The incidence of the cochlear hearing loss in patients 
with chronic renal failure (CRF) exceeds that of an age and 
sex matched normal population. Audiometric hearing loss 
may be defined as an average loss of greater than 20 dB for 
the frequencies 1, 2, 4, 6, 8 kHz[1].
   In the present study, we aimed to evaluate hearing 
threshold and the severity of hearing loss at different 
frequencies in patients with CRF, and to analyze the role 
of duration of disease on hearing threshold in patients 
of CRF by measuring pure-tone audiometry (PTA) and 
distortion-product otoacoustic emission (DPOAE). We 
excluded those patients with etiological factors known to 
predispose to hearing loss such as congenital hearing loss 
(Alport syndrome), middle ear disorders, noise induced 
hearing loss and cochlear ototoxity.
2. Materials and methods
   We analysed 61 patients (122 ears) from which 24 
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subjects were patients undergoing hemodialise over 1 year, 
12 subjects were patients starting hemodialise treatment, 15 
subjects were patients undergoing conservative treatment 
and 10 controls.
   We did hearing evaluation every 3 months for a period 
of one year by using tympanometry, then audiometry and 
DPOAE was applied only for patients with normal middle ear 
condition and hearing threshold better than 30 dBHz.
   DPOAEs reflect non-linear processes of hair cell motion 
and are generated by the active cochlear mechanisms 
responsible for enhancing basilar membrane vibration 
‘cochlear amplifier’.
   Patients with history of otological diseases, ear trauma, 
noise exposure, diabetes mellitus or receiving ototoxic drugs 
were excluded. We selected patients who were relatively 
young (aged less than 50 years old) to avoid the possibility of 
the effect of early presbycusis on the results.
3. Results
3.1. Observations
   In the CRF patients group between the patients just 
starting hemodialise, there were 5 patients out of 12 with 
sensorineural hearing loss (SNHL) especially in high 
frequencies, and in the group with the hemodialised patients 
over a year there were 12 patients out of 24 with SNHL 
(Figure 1).
   All the 17 patients of CRF with SNHL had moderately 
severe to severe degree of hearing loss. As the number of 
hemodialysis increased, the chances of developing SNHL 
and degree also increased. There was a high incidence 
of SNHL even in patients with long standing CRF. In the 
group of patients undergoing conservative treatment, there 
were 6 patients out of 15 with SNHL. As the duration of CRF 
progresses, patients become more prone to develop hearing 
loss.
   DPOAE raised the percentages of detection of SNHL 
indicating that it is a better technique than the conventional 
PTA for evaluation of hearing acuity.
   In the study of control group of 10 healthy volunteers 
(selected from patients of ENT emergency visited for 
different problem than ears problem), only 1 case had SNHL 
which was moderate and of high frequency range.
   All the healthy volunteers had serum creatinine, blood 
urea, serum electrolytes level within normal limits and the 
systolic blood pressure was <140 mmHg.
   Patients with SNHL over 70 dB had significantly low 
sodium and higher potassium and chloride values. This 
showed the role of electrolytes in causing SNHL.
   Serum creatinine indicated the extend of renal disease, 
but its levels were similarly raised in all cases of CRF with 
or without SNHL.
3.2. Blood pressure
   All patients of CRF had raised blood pressure >160 mmHg 
(systolic).
3.3. Blood urea
   All patients of CRF with SNHL had raised blood urea level, 
but this did not go progressively with the number of patients.
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Figure 1. Patient undergoing hemodialisis less than 1 year.
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4. Discussion
   T he  coch lea  and  k idney  may  have  common 
antigenicity[2,3], similar mechanism of the active transport 
of the fluid, electrolytes accomplished by the stria 
vascularis and glomerulus respectively[1,4]. These may 
be the reasons of the similar influence of the the genetic 
factors and similar effects of medication on both organs.
   Several aetiological factors have been linked to hearing 
loss in renal failure[5,6] including the use of ototoxic 
medications, electrolyte disturbances, hypertension[7,8]and 
hemodialisis treatment[9-12]. Brookes suggested that vitamin 
D deficiency might be a contributing factor to hearing loss 
in renal failure[13]. Alder et al. found a significant reduction 
of Na+, K+ activated ATPase in the inner ear of the uremic 
guinea pigs[14].
   From these observations the positive factor which may be 
a cause of hearing loss in CRF patients was long duration 
of the renal failure. The hearing loss on these patients is 
not of genetic origine. It happens even after exclusion of 
known risk factors such as noise exposure, ototoxic drugs, 
head injuries, old age, etc. The presence of additional 
factors accelerate the cause of hearing loss. The presence 
of electrolyte imbalance, hypertension, proteinuria, and 
haemodialysis are some of the factors which seems to have 
cumulative effect on deterioration of hearing in patients 
who were suffering with CRF.
   All patients had SNHL of moderately severe to severe 
degree in high frequency range, which was bilateral and 
symmetrical. The incidence and degree of hearing loss 
increases with the number of haemodialysis. Patients with 
SNHL over 70 dB had significantly low sodium and higher 
potassium and chloride value. All patients who had SNHL 
had long duration of renal failure. All patients of SNHL had 
systolic blood pressure >160 mmHg. The increase level 
of serum creatinine and blood urea cannot predict the 
occurrence of hearing loss.
   So it can be concluded from the study that patients 
suffering from long standing renal failure (long duration) 
had more chances of hearing loss than the healthy 
volunteers and there is cumulative effect of other risk 
factors such as haemodialysis, electrolyte imbalance, 
hypertension, proteinurea on SNHL in CRF patients. 
Hearing loss is becoming increasingly evident, as the 
patients tend to live longer because of improved quality 
of life of CRF patients. The raised blood urea level, serum 
creatinine level, and decrease kidney size does not predict 
the occurrence of SNHL.
   DPOAE raised the percentages of detection of 
SNHL indicating that it is a better technique than the 
conventional pure-tone audiometry for evaluation of 
hearing acuity.
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